Basic Information
LncRNA/CircRNA Name | XLOC_017603 |
Synonyms | NA |
Region | NA |
Ensemble | NA |
Refseq | NA |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | Drug | |||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | hepatocellular carcinoma |
ICD-0-3 | C22.0 |
Methods | RNA-seq, qPCR etc. |
Sample | HCC tissues, cell lines (HBXF344, SNU449, BEL7402, SMMC7721, HePG2, SK-Hep1, PLC/PRF/5, LM3, Hep3B, Huh7, LO2) |
Expression Pattern | down-regulated |
Function Description | In human hepatic cancer, loss of/reduced expression of Lnc-4 (XLOC_017603) was detected in HBXF344, SNU449, BEL7402, SMMC7721, HepG2, SK-Hep1, PLC/PRF/5 and Hep3B cells, It was highly expressed in LM3, Huh7 and LO2 cells. The expression of Lnc-4 was reduced in 41.7% (5/12) of primary hepatic cancer. While high expression level was observed in normal liver tissue. |
Pubmed ID | 27115166 |
Year | 2016 |
Title | Systematic study of novel lncRNAs in different gastrointestinal cancer cells. |
External Links
Links for XLOC_017603 | GenBank HGNC NONCODE |
Links for hepatocellular carcinoma | OMIM COSMIC |